Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
RESEARCH TOOLSreports
Holding SUPN?
Track your performance easily
Supernus Pharmaceuticals (SUPN) Ownership Overview
4.30% Insiders
32.28% Mutual Funds
0.49% Other Institutional Investors
32.50% ETFs
30.43% Public Companies and Individual Investors
The ownership structure of Supernus Pharmaceuticals (SUPN) stock is a mix of institutional, retail, and individual investors. Approximately 65.28% of the company’s stock is owned by Institutional Investors, 4.30% is owned by Insiders, and 30.43% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 29, 2025 | Padmanabh Bhatt Sr. Vp Of Ip, Cso | xxxxxxxxxxxxx | $129676 |
| Dec 04, 2024 | Padmanabh Bhatt Sr. Vp Of Ip, Cso | xxxxxxxxxxxxx | $788437 |
| Nov 12, 2024 | Frederick Hudson Director | xxxxxxxxxxxxx | $316434 |
| Nov 12, 2024 | Jack Khattar Director | xxxxxxxxxxxxx | $4536250 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $1178385 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $5879643 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $5908391 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,454,794 | Institution | 11.69% | 247,283,158 | |
| 5,476,019 | Institution | 9.92% | 209,786,288 | |
| 4,690,543 | Institution | 8.49% | 179,694,702 | |
| 2,008,058 | Institution | 3.64% | 76,928,702 | |
| 1,976,029 | Insider | 3.58% | 75,701,671 | |
| 1,699,603 | Institution | 3.08% | 65,111,791 | |
| 1,551,339 | Institution | 2.81% | 59,431,797 | |
| 1,050,222 | Institution | 1.90% | 40,234,005 | |
| 1,023,856 | Institution | 1.85% | 39,223,923 | |
| 1,002,521 | Institution | 1.82% | 38,406,580 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,690,543 | Institution | 8.49% | 179,694,702 | |
| 2,008,058 | Institution | 3.64% | 76,928,702 | |
| 1,699,603 | Institution | 3.08% | 65,111,791 | |
| 1,050,222 | Institution | 1.90% | 40,234,005 | |
| 667,407 | Institution | 1.21% | 25,568,362 | |
| 576,939 | Institution | 1.04% | 22,102,533 | |
| 568,750 | Institution | 1.03% | 21,788,813 | |
| 533,881 | Institution | 0.97% | 20,452,981 | |
| 391,717 | Institution | 0.71% | 15,006,678 | |
| 358,847 | Institution | 0.65% | 13,747,429 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,540,603 | Institution | 6.41% | 133,905,605 | |
| 1,655,321 | Institution | 3.00% | 60,535,089 | |
| 1,537,215 | Institution | 2.78% | 58,137,471 | |
| 1,333,423 | Institution | 2.41% | 51,083,435 | |
| 1,322,568 | Institution | 2.40% | 48,366,312 | |
| 903,954 | Institution | 1.64% | 34,187,540 | |
| 891,396 | Institution | 1.61% | 32,598,352 | |
| 814,827 | Institution | 1.48% | 29,798,223 | |
| 503,606 | Institution | 0.91% | 19,046,379 | |
| 434,689 | Institution | 0.79% | 16,652,936 |
FAQ
Who Owns Supernus Pharmaceuticals (SUPN)?
According to the latest TipRanks data, approximately 0.49% of the company's stock is held by institutional investors, 4.30% is held by insiders, and 30.43% is held by retail investors.
What percentage of Supernus Pharmaceuticals (SUPN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.49% of Supernus Pharmaceuticals (SUPN) stock is held by institutional investors.
What percentage of Supernus Pharmaceuticals (SUPN) stock is held by retail investors?
According to the latest TipRanks data, approximately 30.43% of Supernus Pharmaceuticals (SUPN) stock is held by retail investors.
Who owns the most shares of Supernus Pharmaceuticals (SUPN)?
iShares owns the most shares of Supernus Pharmaceuticals (SUPN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.